Investing Ideas
/
U.S. High Growth Tech and AI Stocks

U.S. High Growth Tech and AI Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

229

3 new

Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.

229 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
EXEL Exelixis	US$36.20	2.5%	59.9%	US$10.3b	US$35.61	PE22.1x	E20.5%	n/a
TVTX Travere Therapeutics	US$18.37	-1.2%	107.6%	US$1.6b	US$28.13	PS7.9x	E61.9%	n/a
RCEL AVITA Medical	US$8.65	-1.9%	-42.9%	US$228.6m	US$17.34	PS3.8x	E51.8%	n/a
TGTX TG Therapeutics	US$29.55	6.8%	82.2%	US$4.2b	US$41.00	PS16x	E43.9%	n/a
ALKT Alkami Technology	US$35.52	6.0%	42.3%	US$3.6b	US$45.10	PS11.3x	E102.7%	n/a
ALNY Alnylam Pharmaceuticals	US$246.27	-4.6%	33.9%	US$31.8b	US$298.97	PS15.2x	E56.4%	n/a
SMCI Super Micro Computer	US$30.82	-0.8%	-29.4%	US$18.0b	US$40.34	PE14.9x	E24.3%	n/a
ARDX Ardelyx	US$5.01	-14.8%	-43.2%	US$1.2b	US$10.44	PS4.7x	E55.2%	n/a
CLNN Clene	US$4.79	-3.2%	-48.8%	US$38.2m	US$45.17	PS90.8x	E59.1%	n/a
BTDR Bitdeer Technologies Group	US$20.90	22.2%	207.4%	US$3.1b	US$25.02	PS7.8x	E122.5%	n/a
ASFH AsiaFIN Holdings	US$1.26	-16.0%	n/a	US$102.7m	US$2.07	PE1670.2x	E82.7%	n/a
BPMC Blueprint Medicines	US$110.05	6.5%	32.6%	US$7.0b	US$125.47	PS16.1x	E55.3%	n/a
LITE Lumentum Holdings	US$94.41	12.7%	74.3%	US$6.5b	US$93.81	PS4.7x	E117.5%	n/a
GAUZ Gauzy	US$10.84	1.0%	n/a	US$202.6m	US$15.67	PS2.1x	E90.7%	n/a
SPOT Spotify Technology	US$485.53	5.9%	136.1%	US$98.1b	US$483.02	PE136.2x	E29.8%	n/a
TZOO Travelzoo	US$20.98	9.6%	136.8%	US$247.7m	US$25.00	PE18.2x	E34.7%	n/a
SRPT Sarepta Therapeutics	US$118.00	-0.4%	-2.5%	US$11.3b	US$184.91	PE92.5x	E31.8%	n/a
CARG CarGurus	US$37.79	5.1%	60.0%	US$3.9b	US$39.88	PS4.4x	E42.4%	n/a
CAPR Capricor Therapeutics	US$13.70	7.7%	230.1%	US$622.9m	US$41.29	PS26.8x	E55.1%	n/a
MGTX MeiraGTx Holdings	US$6.26	5.9%	-5.0%	US$489.2m	US$21.00	PS35.1x	E27.3%	n/a
ENSC Ensysce Biosciences	US$7.77	8.4%	-54.6%	US$10.1m	US$102.00	PS2.3x	E102.6%	n/a
TNYA Tenaya Therapeutics	US$1.40	-6.7%	-70.5%	US$110.9m	US$18.50	PB1x	E57.8%	n/a
ABEO Abeona Therapeutics	US$5.22	-7.0%	2.8%	US$226.9m	US$15.90	PB5x	E57.8%	n/a
ALDX Aldeyra Therapeutics	US$4.84	1.5%	56.6%	US$288.2m	US$10.00	PB3.4x	E60.0%	n/a

Page 1 of 10